Paget's disease of the bone

Paget's disease of the bone

Paget's disease is a disease of increased but uncontrolled bone turnover. It is thought to be primarily a disorder of osteoclasts, with excessive osteoclastic resorption followed by increased osteoblastic activity

excessive osteoclastic resorption followed by increased osteoblastic activity

You've never been tested on this concept

You've not yet rated this concept.

. Paget's disease is common (UK prevalence 5%) but symptomatic in only 1 in 20 patients. The skull, spine/pelvis, and long bones of the lower extremities are most commonly affected

skull, spine/pelvis, and long bones of the lower extremities are most commonly affected

You've never been tested on this concept

You've not yet rated this concept.

.

Predisposing factors

• increasing age
• male sex
• northern latitude
• family history

Clinical features - only 5% of patients are symptomatic

• the stereotypical presentation is an older male with bone pain and an isolated raised ALP
  Paget's disease - old man, bone pain, raised ALP
  You've never been tested on this concept
  You've not yet rated this concept.
  Importance: 44
• bone pain (e.g. pelvis, lumbar spine, femur)
• classical, untreated features: bowing of tibia, bossing of skull

Investigations

• bloods
  • raised alkaline phosphatase (ALP)
  • calcium and phosphate are typically normal. Hypercalcaemia may occasionally occur with prolonged immobilisation
• other markers of bone turnover include
  • procollagen type I N-terminal propeptide (PINP)
  • serum C-telopeptide (CTx)
  • urinary N-telopeptide (NTx)
  • urinary hydroxyproline
    Paget's disease - increased serum and urine levels of hydroxyproline
    You've never been tested on this concept
    You've not yet rated this concept.
    Importance: 83
• x-rays
  • plain radiographs are the first-line investigation and are usually diagnostic
    plain radiographs are the first-line investigation and are usually diagnostic
    You've never been tested on this concept
    You've not yet rated this concept.
  • osteolysis in early disease → mixed lytic/sclerotic lesions later
  • skull x-ray: thickened vault, osteoporosis circumscripta
• bone scintigraphy
  • increased uptake is seen focally at the sites of active bone lesions

Management

• indications for treatment include
  • bone pain
  • skull or long bone deformity
  • fracture
  • periarticular Paget's
• bisphosphonate
  Paget's disease of the bone is treated with bisphosphonates
  You've never been tested on this concept
  You've not yet rated this concept.
  Importance: 89
  (either oral risedronate or IV zoledronate)
• calcitonin is less commonly used now

Complications

• deafness (cranial nerve entrapment)
• bone sarcoma (1% if affected for > 10 years)
• fractures
• skull thickening
• high-output cardiac failure

+PassMedicine Notes

Paget's disease is a disease of increased but uncontrolled bone turnover. It is thought to be primarily a disorder of osteoclasts, with excessive osteoclastic resorption followed by increased osteoblastic activity. Paget's disease is common (UK prevalence 5%) but symptomatic in only 1 in 20 patients. The skull, spine/pelvis, and long bones of the lower extremities are most commonly affected.

Predisposing factors

• increasing age
• male sex
• northern latitude
• family history

Clinical features - only 5% of patients are symptomatic

• the stereotypical presentation is an older male with bone pain and an isolated raised ALP
• bone pain (e.g. pelvis, lumbar spine, femur)
• classical, untreated features: bowing of tibia, bossing of skull

Investigations

• bloods
• raised alkaline phosphatase (ALP)
• calcium and phosphate are typically normal. Hypercalcaemia may occasionally occur with prolonged immobilisation
• other markers of bone turnover include
• procollagen type I N-terminal propeptide (PINP)
• serum C-telopeptide (CTx)
• urinary N-telopeptide (NTx)
• urinary hydroxyproline
• x-rays
• plain radiographs are the first-line investigation and are usually diagnostic
• osteolysis in early disease --> mixed lytic/sclerotic lesions later
• skull x-ray: thickened vault, osteoporosis circumscripta
• bone scintigraphy
• increased uptake is seen focally at the sites of active bone lesions

Management

• indications for treatment include
• bone pain
• skull or long bone deformity
• fracture
• periarticular Paget's
• bisphosphonate (either oral risedronate or IV zoledronate)
• calcitonin is less commonly used now

Complications

• deafness (cranial nerve entrapment)
• bone sarcoma (1% if affected for > 10 years)
• fractures
• skull thickening
• high-output cardiac failure